In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid
about
Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia (ALL) in first complete remissionAllogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remissionNew and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemiaBest Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on AsparaginaseAllogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioningNovel agents and biomarkers for acute lymphoid leukemiaTreating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristinePrognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemiaOutcomes from unrelated donor hematopoietic stem cell transplantationHow I treat acute lymphoblastic leukemia in older adolescents and young adultsFludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemiaAllogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis.Interpreting outcome data in hematological malignancies: a paradigm for clinical studiesInterpreting outcome data in hematopoietic cell transplantation for leukemia: tackling common biases.Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the InternationalAutologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance).Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemiaUnmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia.Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationAllogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survivalCurrent status and future directions of clinical research and practice in adult acute lymphoblastic leukemia patients in KoreaTreatment of adolescent and young adults with acute lymphoblastic leukemiaMouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology.The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remissionAllogeneic hematopoietic cell transplantation: the state of the artNCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantatioOutcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)Novel therapies for relapsed acute lymphoblastic leukemia.Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.Improved prognosis for older adolescents with acute lymphoblastic leukemia.Biology, risk stratification, and therapy of pediatric acute leukemias: an update.Group sequential tests for long-term survival comparisons.Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD20 expression in acute lymphoblastic leukemia.Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
P2860
Q24234305-0DD987EF-CD51-4FD9-860B-515B930A91E4Q24235952-F4429B23-C76D-4CA0-85F4-A70A59D9EE0BQ26749177-4AAFF3C5-861F-4C60-A6B3-1FDEFD2F9D7CQ26784116-5FD9AA88-9CAF-4A64-A70F-C1EDDA3CDE5AQ26795740-8C74C94A-767F-4760-A28A-EA905F4C35AFQ26829775-53330592-A72D-41EA-B57C-48F372C1CE92Q27000078-BA0F29EF-EA4B-4165-A3B9-BE8E979153DCQ27006773-FA2EB018-CB91-4B20-BB36-1F90E7E30A4DQ27027854-D6B4F849-22EC-445E-BC49-183DEE47933EQ28087589-EBF6A591-C9D4-4A2C-B21E-BE267BC8FE5BQ30276948-B68DCE1A-2F26-4846-8DF2-3B2265F252DDQ30577948-59B9524E-EAF7-4683-83E7-0EF2C60BB9F5Q30658847-9E6DA42D-7322-450B-805A-A126E9D50A36Q30884173-4CAEA70C-61C5-4097-8CA2-BB1F02B8A27FQ33412662-CB591291-6C53-4255-A76D-CB9A13B4372BQ33558183-FBCAC7DC-BBD1-4B57-8019-EC063666DB34Q33605181-CCF83A56-86D1-4909-94A1-FE67854361A1Q33621937-ACC62318-DA00-465A-A55D-C766221BA3F6Q33742940-969DE745-BE49-4E96-AFC5-1AC0563C050FQ33747668-6D2CA701-B9B8-473E-B75E-2EA50FF601E1Q33762835-C628A58B-D078-4F5B-B295-B06FA92DC550Q33780277-52EB71FA-E875-4B0A-AF17-3137230479BFQ33816659-3B1F64F6-EF3D-45EC-ACB3-B3494D10F833Q33875893-07F0F10C-1D0C-43E5-85D7-3CD586C90096Q33920153-37D8534C-2ABB-457E-8181-051837A7FD73Q34016431-196F4CE0-4C2A-4355-9D26-EE525D2E2520Q34033852-B3BC350C-5A02-45D2-956A-DB42CDC40D09Q34145155-898E40C0-A814-41A3-8689-2657B311D391Q34202277-ABD0D763-EDD3-4E9D-8FF1-D51235B8E049Q34300854-375B4101-32AA-47BC-BE30-3BF09B558DA6Q34455093-29EC830D-6C1A-4A9B-9D25-C4D7730538A8Q34532041-2FFB7CD0-A438-4946-9F6E-B0F31AD174D2Q34612782-A4FF50AE-1095-4802-AB03-9310112864FBQ34619129-FB2DD4CE-6AE4-451F-AD46-58976FFAABD9Q34645985-75BBE4B6-539B-4A7A-BAD4-20FF0CE657CFQ34679298-104AE63C-A679-48A4-9354-9A4A43FE8B6BQ34764504-FF20F05A-48C9-405E-BE4B-B47E341ED045Q35008032-DEE2468A-23C7-4878-A3A4-8F7C073324DAQ35029453-863E6370-BA88-422B-AD81-9993FF72B2EEQ35057041-A033B845-390E-4F07-BE44-31B6EDFA3EA4
P2860
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
In adults with standard-risk a ...... ive than conventional consolid
@en
In adults with standard-risk a ...... ive than conventional consolid
@nl
type
label
In adults with standard-risk a ...... ive than conventional consolid
@en
In adults with standard-risk a ...... ive than conventional consolid
@nl
prefLabel
In adults with standard-risk a ...... ive than conventional consolid
@en
In adults with standard-risk a ...... ive than conventional consolid
@nl
P2093
P50
P1433
P1476
In adults with standard-risk a ...... ive than conventional consolid
@en
P2093
Adele K Fielding
Alan K Burnett
Andrew McMillan
Anthony H Goldstone
David I Marks
Georgina Buck
Ian M Franklin
Jacob M Rowe
Jill Durrant
Letizia Foroni
P304
P356
10.1182/BLOOD-2007-10-116582
P407
P577
2007-11-29T00:00:00Z